Yanjun Guo

1.6k citations
9 papers · 1.2k indexed · 1 hit paper · h-index 7
Topics
Cancer-related molecular mechanisms research (3 papers)MicroRNA in disease regulation (2 papers)Adenosine and Purinergic Signaling (1 paper)

In The Last Decade

Yanjun Guo

8 papers receiving 1.2k citations

Hit Papers

ERK/MAPK signalling pathway and tumorigenesis (Review)202020262022202420202505007501000

Peers

Yanjun Guo
Comparison fields: 5 of 102
  • Molecular Biology 760
  • Cancer Research 288
  • Oncology 234
  • Pulmonary and Respiratory Medicine 125
  • Immunology 118
Replace Seon Min Woo with:
Seon Min Woo South Korea
Yuanyuan Weng China
Deqiang Huang China
Xin Peng China
Chun Wang China
Jian Liang China
Nam Nhut Phan Taiwan
Timothy Hadden United States
Yancun Yin China
Yanjun Guo relative to Seon Min Woo South Korea Seon Min Woo's profile →
Citations per field
00.5×1.5×1.9×
Seon Min Woo · 1×
Citations per year

Countries citing papers authored by Yanjun Guo

Since Specialization
Citations

This map shows the geographic impact of Yanjun Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanjun Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanjun Guo more than expected).

Fields of papers citing papers by Yanjun Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanjun Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanjun Guo. The network helps show where Yanjun Guo may publish in the future.

Co-authorship network of co-authors of Yanjun Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Yanjun Guo. A scholar is included among the top collaborators of Yanjun Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanjun Guo. Yanjun Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
#WorkIndexed citations
1 0
2 1
3 41
4
ERK/MAPK signalling pathway and tumorigenesis (Review)breakdown →
1100
5 15
6 7
7 33
8 14
9 16

About Yanjun Guo

Yanjun Guo is a scholar working on Cancer Research, Physiology and Immunology and Allergy, having authored 9 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (3 papers), MicroRNA in disease regulation (2 papers) and Adenosine and Purinergic Signaling (1 paper). The work is most often cited by research in Cancer Research (288 citations), Molecular Biology (760 citations) and Oncology (234 citations). Yanjun Guo has collaborated with scholars based in China, Netherlands and New Zealand. Frequent co-authors include Ying Xu, Zhong‐Fei Shen, Shengbing Liu, Weiwei Pan, Lingling Hu, Wei Yan, Yong Chen, Yuping Wang, Qiang Li and Yong Chen. Their work appears in journals such as Scientific Reports, International Journal of Molecular Sciences and Cellular and Molecular Life Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026